Priscilla W.

Priscilla W. currently serves as a Clinical Data Science Associate at Revolution Medicines, beginning in April 2024. Previously, in the role of Associate Scientist at Senti Biosciences from February 2020 to January 2024, Priscilla was integral to the development of SENTI-401 for colorectal cancer and other solid tumors, overseeing data verification for pre-clinical study reports and collaborating with external organizations on viral vector production. Priscilla's earlier experience includes Senior Research Associate roles at Senti Biosciences, where contributions were made to the SENTI-301A CAR-NK cell therapy project, and Research Associate II at Caribou Biosciences, focusing on the CB-020 CAR-NK platform. Additionally, Priscilla worked at the University of California, San Francisco, as a Lab Manager and in various research associate and assistant positions, accumulating extensive expertise in cell biology and laboratory management. Priscilla holds a B.S. in Molecular, Cell, and Developmental Biology with a minor in Chemistry from the University of California, Santa Cruz.